Lv5
1250 积分 2023-05-08 加入
新生儿Fc受体抑制剂在神经系统自身免疫性疾病治疗中的研究进展
3天前
已完结
The multiple facets of FcRn in immunity
4天前
已完结
Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus
9天前
已完结
Telitacicept: First Approval
9天前
已完结
B cell-activating factor and its targeted therapy in autoimmune diseases
10天前
已完结
Rusfertide (PTG-300) Induction Therapy Rapidly Achieves Hematocrit Control in Polycythemia Vera Patients without the Need for Therapeutic Phlebotomy
19天前
已关闭
Rusfertide (PTG-300) Induction Therapy Rapidly Achieves Hematocrit Control in Polycythemia Vera Patients without the Need for Therapeutic Phlebotomy
19天前
已关闭
Rusfertide (PTG-300) Induction Therapy Rapidly Achieves Hematocrit Control in Polycythemia Vera Patients without the Need for Therapeutic Phlebotomy
19天前
已关闭
The evolving landscape of polycythemia vera therapies
21天前
已完结
Multiple‐Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects
21天前
已完结
皖公网安备34019202002308
